Parameters   Placebo B. coagulans P value Δ
(N=20) MTCC 5856
   (N=18)
Weight (Kg)
  Baseline (Day 0) 72.2 ± 12.8 68.8 ± 13.6 0.598
End of Study (Day 30) 71.8 ± 13.5 69.4 ± 14 0.604
Change From Baseline to Day 30 p = 0.429 p = 0.390 0.968
BMI (kg/m2)
  Baseline (Day 0) 24.6 ± 2.7 24.5 ± 3 0.731
End of Study (Day 30) 24.4 ± 2.9 24.3 ± 3.3 0.869
Change From Baseline to Day 30 p = 0.381 p = 0.353 0.897
Heart Rate (BPM)
  Baseline (Day 0) 68.3 ± 7.5 68.9 ± 8.4 0.839
End of Study (Day 30) 65.9 ± 6.8 69.2 ± 8.6 0.193
Change From Baseline to Day 30 p = 0.157 p = 0.486 0.159
Systolic Blood Pressure (mmHg)
  Baseline (Day 0) 100.4 ± 10.3 104.0 ± 9.4 0.253
End of Study (Day 30) 104.9 ± 10.4 100.0 ± 9.0 0.127
Change From Baseline to Day 30 p = 0.023 p = 0.100 0.006
Diastolic Blood Pressure (mmHg)
  Baseline (Day 0) 66.5 ± 7.6 68.4 ± 6.7 0.428
End of Study (Day 30) 67.4 ± 7.6 69.0 ± 7.9 0.547
Change From Baseline to Day 30 p = 0.590 p = 0.852 0.796
Table 2: Anthropometrics and Vital Signs for All Participants at Baseline and after 30 Days of Supplementation with B. coagulans MTCC 5856 or Placebo BPM, beats per minute; mmHg, millimeter of mercury; kg, kilograms; BMI, body mass index; kg/m2, kilograms per square meter. Δ Between-group comparisons were made using the unpaired Student’s t-test. Within-group comparisons were made using the paired Student’s t-test. Probability (p) values ≤0.05 are statistically significant.